Chromatin-modifying protein 4C (CHMP4C) affects breast cancer cell growth and doxorubicin resistance as a potential breast cancer therapeutic target

Kim YJ, Jang SK, Kim G, Hong SE, Park CS, Seong MK, et al. Nebivolol sensitizes BT-474 breast cancer cells to FGFR inhibitors. Anticancer Res. 2023;43:1973–80.

Article  CAS  PubMed  Google Scholar 

Yamanaka T, Oshima T, Murayama D, Okamoto S, Matsui AI, Yasukawa M, et al. Clinical significance of cancer stem cell markers in primary and metastatic tissues in patients with breast cancer. Anticancer Res. 2023;43:2145–54.

Article  CAS  PubMed  Google Scholar 

Das CK, Linder B, Bonn F, Rothweiler F, Dikic I, Michaelis M, et al. BAG3 overexpression and cytoprotective autophagy mediate apoptosis resistance in chemoresistant breast cancer cells. Neoplasia. 2018;20:263–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu H, Yan R, Xiao Z, Huang X, Yao J, Liu J, et al. Targeting DCLK1 attenuates tumor stemness and evokes antitumor immunity in triple-negative breast cancer by inhibiting IL-6/STAT3 signaling. Breast Cancer Res. 2023;25:43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wei X, Yang M. Cell- and subcellular organelle-targeting nanoparticle-mediated breast cancer therapy. Front Pharmacol. 2023;14:1180794.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zaib S, Tahir S, Masood N, Hameed A, Azra Y. A meta-analysis and experimental data for multidrug resistance genes in breast cancer. Afr Health Sci. 2022;22:1–9.

Article  PubMed  PubMed Central  Google Scholar 

Li J. Chidamide enhances cytotoxicity of doxorubicin by promoting autophagy and apoptosis in breast cancer. BMC Cancer. 2023;23:353.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin SL, Wang M, Cao QQ, Li Q. Chromatin modified protein 4C (CHMP4C) facilitates the malignant development of cervical cancer cells. FEBS Open Bio. 2020;10:1295–303.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carlton JG, Caballe A, Agromayor M, Kloc M, Martin-Serrano J. ESCRT-III governs the Aurora B-mediated abscission checkpoint through CHMP4C. Science. 2012;336:220–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Petsalaki E, Dandoulaki M, Zachos G. The ESCRT protein Chmp4c regulates mitotic spindle checkpoint signaling. J Cell Biol. 2018;217:861–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Petsalaki E, Zachos G. CHMP4C: a novel regulator of the mitotic spindle checkpoint. Mol Cell Oncol. 2018;5:e1445944.

Article  PubMed  PubMed Central  Google Scholar 

Chen Y, Liu Y, Wang M. Identification of a pyroptosis-related gene signature and effect of silencing the CHMP4C and CASP4 in pancreatic adenocarcinoma. Int J Gen Med. 2022;15:3199–213.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu B, Guo S, Li GH, Liu Y, Liu XZ, Yue JB, et al. CHMP4C regulates lung squamous carcinogenesis and progression through cell cycle pathway. J Thorac Dis. 2021;13:4762–74.

Article  PubMed  PubMed Central  Google Scholar 

Li K, Liu J, Tian M, Gao G, Qi X, Pan Y, et al. CHMP4C disruption sensitizes the human lung cancer cells to irradiation. Int J Mol Sci. 2015;17.

Xu S, Li X, Li W, Ma N, Ma H, Cui J, et al. Sufentanil combined with parecoxib sodium inhibits proliferation and metastasis of HER2-positive breast cancer cells and regulates epithelial-mesenchymal transition. Clin Exp Metastasis. 2023;40:149–60.

Article  CAS  PubMed  Google Scholar 

Azadeh M, Salehzadeh A, Ghaedi K, Talesh Sasani S. NEAT1 can be a diagnostic biomarker in the breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: integrated RNA targetome interaction and experimental expression analysis. Genes Environ. 2022;44:16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Camilloni A, Nati G, Maggiolini P, Romanelli A, Latina R. Chronic non-cancer pain in primary care: an Italian cross-sectional study. Signa Vitae. 2021;7:54–62.

Google Scholar 

Dai R, Peng X, Lin B, Xu D, Lv R. NIR II luminescence imaging for sentinel lymph node and enhanced chemo-/photothermal therapy for breast cancer. Bioconjugate Chem. 2021;32:2117–27.

Article  CAS  Google Scholar 

Petsalaki E, Dandoulaki M, Zachos G. Chmp4c is required for stable kinetochore-microtubule attachments. Chromosoma. 2018;127:461–73.

Article  CAS  PubMed  Google Scholar 

Casares-Arias J, Gonzalez MU, San Paulo A, Ventimiglia LN, Sadler JBA, Miguez DG, et al. Midbody remnant inheritance is regulated by the ESCRT subunit CHMP4C. iScience. 2020;23:101244.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang XX, Ma M, Sang MX, Zhang XY, Zou NY, Zhu SC. Knockdown of FAM83D enhances radiosensitivity in coordination with irradiation by inhibiting EMT via the Akt/GSK-3beta/Snail signaling pathway in human esophageal cancer cells. OncoTargets Ther. 2020;13:4665–78.

Article  CAS  Google Scholar 

Huang Y, Guo Y, Xu Y, Liu F, Dai S. Flotillin-1 promotes EMT of gastric cancer via stabilizing Snail. PeerJ. 2022;10:e13901.

Article  PubMed  PubMed Central  Google Scholar 

Gao Y, Xiang D, Li W, Zheng X, Wang L, Li Z, et al. BRAF(V600E) mutation-responsive miRNA-222-3p promotes metastasis of papillary thyroid cancer cells via snail-induced EMT. Front Endocrinol. 2022;13:843334.

Article  Google Scholar 

Wang WD, Shang Y, Li Y, Chen SZ. Honokiol inhibits breast cancer cell metastasis by blocking EMT through modulation of Snail/Slug protein translation. Acta Pharm Sin. 2019;40:1219–27.

Article  CAS  Google Scholar 

Mezencev R, Matyunina LV, Jabbari N, McDonald JF. Snail-induced epithelial-to-mesenchymal transition of MCF-7 breast cancer cells: systems analysis of molecular changes and their effect on radiation and drug sensitivity. BMC Cancer. 2016;16:236.

Article  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif